Bristol Myers, J&J drugs reduce COVID-19 death rates in NIH study - CNA

6/2/2022 12:00:00 AM2 years 11 months ago

A late-stage study of two rheumatoid arthritis drugs from Bristol Myers Squibb and Johnson & Johnson showed a significant drop in deaths among hospitalised COVID patients, a US health agency said on Thursday (Jun 2). However, both the drugs failed to meet …

A late-stage study of two rheumatoid arthritis drugs from Bristol Myers Squibb and Johnson & Johnson showed a significant drop in deaths among hospitalised COVID patients, a US health agency said… [+1211 chars]

full article...